Lupin is no stranger to recalls, and has at times even had to suspend production of U.S.-bound drugs at its plants. In late November, Lupin recalled more than 600,000 bottles of the high blood ...

Indian generics manufacturer Lupin has suspended production of drugs bound for the U.S. from a troubled active pharmaceutical ingredient plant in India, according to an FDA warning letter.

Lupin has launched eslicarbazepine acetate ... tablets are the generic of Sumitomo Pharma America’s Aptiom. The medication is indicated for the treatment of partial-onset seizures in patients ...

the U.S. arm of Indian pharmaceutical giant Lupin Ltd., has voluntarily recalled two Tydemy birth control pill batches. The reason was that the pills in question tested low for ascorbic acid and ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary ...

Ramesh Swaminathan, Global CFO of Lupin discusses the impact of Trump's win on the Indian pharmaceutical sector. Growing demand for affordable medicines, and diversification from China are key ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced a settlement agreement with Lupin Limited, resolving the patent infringement litigation related to Lupin’s Abbreviated New Drug ...

The pharmaceutical company behind the birth control pill Tydemy is recalling two batches of the drug because they may have reduced effectiveness. Lupin, the New Jersey-based drugmaker, announced ...

The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily ...

Lupin Digital Health, drugmaker Lupin's digital therapeutics arm that focuses on cardiac rehabilitation and care, has doubled its patient base to 10,000 in the past year and expects to grow ...